Product Code: PM1316
The global blood transfusion diagnostics market size is expected to reach USD 6.66 billion by 2032, according to a new study by Polaris Market Research. The report "Blood Transfusion Diagnostics Market Share, Size, Trends, Industry Analysis Report, By Product (Instruments, Reagents & Kits, Others); By Application; By End-Use; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The rising shift toward automation in blood banks is anticipated to aid blood collection facilities by reducing the time required to complete tests and addressing the workforce shortage needed to conduct essential tests. The implementation of automated systems is expected to help these facilities streamline their workflow and improve overall efficiency.
The proper handling and storage of blood and blood products is critical to blood transfusion diagnostics, as is the implementation of quality control methods. Blood is tested for microbial contamination on a regular basis, and it is thoroughly examined to ensure accurate labeling and documentation before it is approved for transfusion.
The global rise in chronic diseases such as cancer, sickle cell anemia, and thalassemia has resulted in an increase in blood transfusions, which has contributed to the market's growth. The demand for blood transfusion diagnostics has also increased as the number of traffic accidents, trauma cases, and blood transfusion procedures has increased.
Government initiatives and legislative measures mandating the use of blood transfusion diagnostics are critical to market growth. Particularly, regulations enacted by the United States Food and Drug Administration (FDA) require the use of Nucleic Acid Testing (NAT) to detect viral infections in donated blood. This critical step significantly reduces the risk of blood-borne disease transmission.
Automation and technological advancements in diagnostic testing methods, such as nucleic acid testing and immunoassays, have enhanced the accuracy and efficiency of blood screening. Similarly, there is a growing emphasis on improving the safety of blood transfusions by reducing the risk of transfusion-transmissible infections. The market has shifted toward molecular diagnostic techniques for the rapid and sensitive detection of pathogens. With an emphasis on blood safety, the blood transfusion diagnostics market is likely to continue evolving with innovations that simplify processes and improve the overall efficiency of blood testing and transfusion procedures.
Blood Transfusion Diagnostics Market Report Highlights
The reagent & kits segment held the largest revenue share in the blood transfusion diagnostics market. Medical facilities rely on the repeated use of reagents and kits to ensure the safe and effective transfusion of blood. These essential tools are used for a variety of purposes, including blood grouping and typing.
The disease screening segment accounted for the highest market share during the forecast period. Disease screening is essential in protecting the recipient's health and preventing the spread of infections through donated blood. Blood transfusion safety has become increasingly important in the prevention of infection transmission.
North America accounted for the largest market share in the blood transfusion diagnosis market, owing to the high disposable income, favorable reimbursement policies, rising health awareness, and a well-established healthcare infrastructure.
The Asia-Pacific region witnessed for the fastest growth in the blood transfusion diagnostics market owing to the high frequency of TTIs in countries with low income which give rise to a huge need for illness screening techniques. However, the number of blood donation centers and donors is steadily increasing. Additionally, there is an increase in demand for pre-transfusion testing.
The global key market players include Abbott Laboratories, Bio-Rad Laboratories, Inc., Diamond Diagnostics, Diagnostica Stago, Electro Medical Technologies, F. Hoffman-La Roche Ltd., Grifols S.A., Immucor Inc., Ortho Clinical Diagnosis, Quotient Ltd.
Polaris Market Research has segmented the Blood Transfusion Diagnostics market report based on product, application, end-use, and region:
Blood Transfusion Diagnostics, Product Outlook (Revenue - USD Billion, 2019 - 2032)
- Instrument
- Reagents & Kits
- Others
Blood Transfusion Diagnostics, Application Outlook (Revenue - USD Billion, 2019 - 2032)
- Blood Grouping
- Disease Screening
- Serological
- Molecular
Blood Transfusion Diagnostics, End-Use Outlook (Revenue - USD Billion, 2019 - 2032)
- Hospitals
- Blood Banks
- Diagnostic Laboratories
- Others
Blood Transfusion Diagnostics, Regional Outlook (Revenue - USD Billion, 2019 - 2032)
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Netherlands
- Asia Pacific
- China
- India
- Japan
- South Korea
- Indonesia
- Malaysia
- Latin America
- Argentina
- Brazil
- Mexico
- Middle East & Africa
- UAE
- Saudi Arabia
- Israel
- South Africa
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
3. Research Methodology
- 3.1. Overview
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Blood Transfusion Diagnostics Market Insights
- 4.1. Blood Transfusion Diagnostics - Industry snapshot
- 4.2. Blood Transfusion Diagnostics Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Improvements in the diagnostic technologies will drive the growth of the market
- 4.2.1.2. Increase in the number of trauma & road accident cases will bolster the growth of the market
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Shortage of blood donations as compared to the demand will hamper on the growth of the market
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTLE Analysis
- 4.5. Blood Transfusion Diagnostics Market Industry trends
5. Global Blood Transfusion Diagnostics Market Assessment by Product
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Blood Transfusion Diagnostics Market, By Product, 2019 - 2032 (USD Billion)
- 5.3. Instruments
- 5.3.1. Global Blood Transfusion Diagnostics Market, by Instruments, by Region, 2019 - 2032 (USD Billion)
- 5.4. Reagents & Kits
- 5.4.1. Global Blood Transfusion Diagnostics Market, by Reagents & Kits, by Region, 2019 - 2032 (USD Billion)
- 5.5. Others
- 5.5.1. Global Blood Transfusion Diagnostics Market, by Others, by Region, 2019 - 2032 (USD Billion)
6. Global Blood Transfusion Diagnostics Market, by Application
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Blood Transfusion Diagnostics Market, By Application, 2019 - 2032 (USD Billion)
- 6.3. Blood Grouping
- 6.3.1. Global Blood Transfusion Diagnostics Market, by Blood Grouping, By Region, 2019 - 2032 (USD Billion)
- 6.4. Disease Screening
- 6.4.1. Global Blood Transfusion Diagnostics Market, by Disease Screening, by Region, 2019 - 2032 (USD Billion)
- 6.4.2. Serological
- 6.4.2.1. Serological Screening Market, by Disease, by Region, 2019 - 2032 (USD Billion)
- 6.4.3. Molecular
- 6.4.3.1. Molecular Screening Screening Market, by Disease, by Region, 2019 - 2032 (USD Billion)
7. Blood Transfusion Diagnostics Market Assessment by End-Use
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Blood Transfusion Diagnostics Market, By End-Use, 2019 - 2032 (USD Billion)
- 7.3. Hospitals
- 7.3.1. Global Blood Transfusion Diagnostics Market, by Hospitals, by Region, 2019 - 2032 (USD Billion)
- 7.4. Blood Banks
- 7.4.1. Global Blood Transfusion Diagnostics Market, by Blood Banks, by Region, 2019 - 2032 (USD Billion)
- 7.5. Diagnostic Laboratories
- 7.5.1. Global Blood Transfusion Diagnostics Market, by Diagnostic Laboratories, by Region, 2019 - 2032 (USD Billion)
- 7.6. Others
- 7.6.1. Global Blood Transfusion Diagnostics Market, by Others, by Region, 2019 - 2032 (USD Billion)
8. Blood Transfusion Diagnostics Market Assessment by Geography
- 8.1. Key findings
- 8.2. Introduction
- 8.2.1. Blood Transfusion Diagnostics Market Assessment, By Geography, 2019 - 2032 (USD Billion)
- 8.3. Blood Transfusion Diagnostics Market - North America
- 8.3.1. North America: Blood Transfusion Diagnostics Market, By Product, 2019 - 2032 (USD Billion)
- 8.3.2. North America: Blood Transfusion Diagnostics Market, By Application, 2019 - 2032 (USD Billion)
- 8.3.3. North America: Blood Transfusion Diagnostics Market, By End Use, 2019 - 2032 (USD Billion)
- 8.3.4. Blood Transfusion Diagnostics Market - U.S.
- 8.3.4.1. U.S.: Blood Transfusion Diagnostics Market, By Product, 2019 - 2032 (USD Billion)
- 8.3.4.2. U.S.: Blood Transfusion Diagnostics Market, By Application, 2019 - 2032 (USD Billion)
- 8.3.4.3. U.S.: Blood Transfusion Diagnostics Market, By End Use, 2019 - 2032 (USD Billion)
- 8.3.5. Blood Transfusion Diagnostics Market - Canada
- 8.3.5.1. Canada: Blood Transfusion Diagnostics Market, By Product, 2019 - 2032 (USD Billion)
- 8.3.5.2. Canada.: Blood Transfusion Diagnostics Market, By Application, 2019 - 2032 (USD Billion)
- 8.3.5.3. Canada: Blood Transfusion Diagnostics Market, By End Use, 2019 - 2032 (USD Billion)
- 8.4. Blood Transfusion Diagnostics Market - Europe
- 8.4.1. Europe: Blood Transfusion Diagnostics Market, By Product, 2019 - 2032 (USD Billion)
- 8.4.2. Europe.: Blood Transfusion Diagnostics Market, By Application, 2019 - 2032 (USD Billion)
- 8.4.3. Europe: Blood Transfusion Diagnostics Market, By End Use, 2019 - 2032 (USD Billion)
- 8.4.4. Blood Transfusion Diagnostics Market - UK
- 8.4.4.1. UK: Blood Transfusion Diagnostics Market, By Product, 2019 - 2032 (USD Billion)
- 8.4.4.2. UK.: Blood Transfusion Diagnostics Market, By Application, 2019 - 2032 (USD Billion)
- 8.4.4.3. UK: Blood Transfusion Diagnostics Market, By End Use, 2019 - 2032 (USD Billion)
- 8.4.5. Blood Transfusion Diagnostics Market - France
- 8.4.5.1. France: Blood Transfusion Diagnostics Market, By Product, 2019 - 2032 (USD Billion)
- 8.4.5.2. France.: Blood Transfusion Diagnostics Market, By Application, 2019 - 2032 (USD Billion)
- 8.4.5.3. France: Blood Transfusion Diagnostics Market, By End Use, 2019 - 2032 (USD Billion)
- 8.4.6. Blood Transfusion Diagnostics Market - Germany
- 8.4.6.1. Germany: Blood Transfusion Diagnostics Market, By Product, 2019 - 2032 (USD Billion)
- 8.4.6.2. Germany.: Blood Transfusion Diagnostics Market, By Application, 2019 - 2032 (USD Billion)
- 8.4.6.3. Germany: Blood Transfusion Diagnostics Market, By End Use, 2019 - 2032 (USD Billion)
- 8.4.7. Blood Transfusion Diagnostics Market - Italy
- 8.4.7.1. Italy: Blood Transfusion Diagnostics Market, By Product, 2019 - 2032 (USD Billion)
- 8.4.7.2. Italy.: Blood Transfusion Diagnostics Market, By Application, 2019 - 2032 (USD Billion)
- 8.4.7.3. Italy: Blood Transfusion Diagnostics Market, By End Use, 2019 - 2032 (USD Billion)
- 8.4.8. Blood Transfusion Diagnostics Market - Spain
- 8.4.8.1. Spain: Blood Transfusion Diagnostics Market, By Product, 2019 - 2032 (USD Billion)
- 8.4.8.2. Spain.: Blood Transfusion Diagnostics Market, By Application, 2019 - 2032 (USD Billion)
- 8.4.8.3. Spain: Blood Transfusion Diagnostics Market, By End Use, 2019 - 2032 (USD Billion)
- 8.4.9. Blood Transfusion Diagnostics Market - Netherlands
- 8.4.9.1. Netherlands: Blood Transfusion Diagnostics Market, By Product, 2019 - 2032 (USD Billion)
- 8.4.9.2. Netherlands.: Blood Transfusion Diagnostics Market, By Application, 2019 - 2032 (USD Billion)
- 8.4.9.3. Netherlands: Blood Transfusion Diagnostics Market, By End Use, 2019 - 2032 (USD Billion)
- 8.4.10. Blood Transfusion Diagnostics Market - Austria
- 8.4.10.1. Austria: Blood Transfusion Diagnostics Market, By Product, 2019 - 2032 (USD Billion)
- 8.4.10.2. Austria.: Blood Transfusion Diagnostics Market, By Application, 2019 - 2032 (USD Billion)
- 8.4.10.3. Austria: Blood Transfusion Diagnostics Market, By End Use, 2019 - 2032 (USD Billion)
- 8.5. Blood Transfusion Diagnostics Market - Asia-Pacific
- 8.5.1. Asia Pacific: Blood Transfusion Diagnostics Market, By Product, 2019 - 2032 (USD Billion)
- 8.5.2. Asia Pacific.: Blood Transfusion Diagnostics Market, By Application, 2019 - 2032 (USD Billion)
- 8.5.3. Asia Pacific: Blood Transfusion Diagnostics Market, By End Use, 2019 - 2032 (USD Billion)
- 8.5.4. Blood Transfusion Diagnostics Market - China
- 8.5.4.1. China: Blood Transfusion Diagnostics Market, By Product, 2019 - 2032 (USD Billion)
- 8.5.4.2. China.: Blood Transfusion Diagnostics Market, By Application, 2019 - 2032 (USD Billion)
- 8.5.4.3. China: Blood Transfusion Diagnostics Market, By End Use, 2019 - 2032 (USD Billion)
- 8.5.5. Blood Transfusion Diagnostics Market - India
- 8.5.5.1. India: Blood Transfusion Diagnostics Market, By Product, 2019 - 2032 (USD Billion)
- 8.5.5.2. India.: Blood Transfusion Diagnostics Market, By Application, 2019 - 2032 (USD Billion)
- 8.5.5.3. India: Blood Transfusion Diagnostics Market, By End Use, 2019 - 2032 (USD Billion)
- 8.5.6. Blood Transfusion Diagnostics Market - Malaysia
- 8.5.6.1. Malaysia: Blood Transfusion Diagnostics Market, By Product, 2019 - 2032 (USD Billion)
- 8.5.6.2. Malaysia.: Blood Transfusion Diagnostics Market, By Application, 2019 - 2032 (USD Billion)
- 8.5.6.3. Malaysia: Blood Transfusion Diagnostics Market, By End Use, 2019 - 2032 (USD Billion)
- 8.5.7. Blood Transfusion Diagnostics Market - Japan
- 8.5.7.1. Japan: Blood Transfusion Diagnostics Market, By Product, 2019 - 2032 (USD Billion)
- 8.5.7.2. Japan.: Blood Transfusion Diagnostics Market, By Application, 2019 - 2032 (USD Billion)
- 8.5.7.3. Japan: Blood Transfusion Diagnostics Market, By End Use, 2019 - 2032 (USD Billion)
- 8.5.8. Blood Transfusion Diagnostics Market - Indonesia
- 8.5.8.1. Indonesia: Blood Transfusion Diagnostics Market, By Product, 2019 - 2032 (USD Billion)
- 8.5.8.2. Indonesia.: Blood Transfusion Diagnostics Market, By Application, 2019 - 2032 (USD Billion)
- 8.5.8.3. Indonesia: Blood Transfusion Diagnostics Market, By End Use, 2019 - 2032 (USD Billion)
- 8.5.9. Blood Transfusion Diagnostics Market - South Korea
- 8.5.9.1. South Korea: Blood Transfusion Diagnostics Market, By Product, 2019 - 2032 (USD Billion)
- 8.5.9.2. South Korea.: Blood Transfusion Diagnostics Market, By Application, 2019 - 2032 (USD Billion)
- 8.5.9.3. South Korea: Blood Transfusion Diagnostics Market, By End Use, 2019 - 2032 (USD Billion)
- 8.6. Blood Transfusion Diagnostics Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Blood Transfusion Diagnostics Market, By Product, 2019 - 2032 (USD Billion)
- 8.6.2. Middle East & Africa.: Blood Transfusion Diagnostics Market, By Application, 2019 - 2032 (USD Billion)
- 8.6.3. Middle East & Africa: Blood Transfusion Diagnostics Market, By End Use, 2019 - 2032 (USD Billion)
- 8.6.4. Blood Transfusion Diagnostics Market - Saudi Arabia
- 8.6.4.1. Saudi Arabia: Blood Transfusion Diagnostics Market, By Product, 2019 - 2032 (USD Billion)
- 8.6.4.2. Saudi Arabia.: Blood Transfusion Diagnostics Market, By Application, 2019 - 2032 (USD Billion)
- 8.6.4.3. Saudi Arabia: Blood Transfusion Diagnostics Market, By End Use, 2019 - 2032 (USD Billion)
- 8.6.5. Blood Transfusion Diagnostics Market - UAE
- 8.6.5.1. UAE: Blood Transfusion Diagnostics Market, By Product, 2019 - 2032 (USD Billion)
- 8.6.5.2. UAE.: Blood Transfusion Diagnostics Market, By Application, 2019 - 2032 (USD Billion)
- 8.6.5.3. UAE: Blood Transfusion Diagnostics Market, By End Use, 2019 - 2032 (USD Billion)
- 8.6.6. Blood Transfusion Diagnostics Market - Israel
- 8.6.6.1. Israel: Blood Transfusion Diagnostics Market, By Product, 2019 - 2032 (USD Billion)
- 8.6.6.2. Israel.: Blood Transfusion Diagnostics Market, By Application, 2019 - 2032 (USD Billion)
- 8.6.6.3. Israel: Blood Transfusion Diagnostics Market, By End Use, 2019 - 2032 (USD Billion)
- 8.6.7. Blood Transfusion Diagnostics Market - South Africa
- 8.6.7.1. South Africa: Blood Transfusion Diagnostics Market, By Product, 2019 - 2032 (USD Billion)
- 8.6.7.2. South Africa.: Blood Transfusion Diagnostics Market, By Application, 2019 - 2032 (USD Billion)
- 8.6.7.3. South Africa: Blood Transfusion Diagnostics Market, By End Use, 2019 - 2032 (USD Billion)
- 8.7. Blood Transfusion Diagnostics Market - Latin America
- 8.7.1. Latin America: Blood Transfusion Diagnostics Market, By Product, 2019 - 2032 (USD Billion)
- 8.7.2. Latin America.: Blood Transfusion Diagnostics Market, By Application, 2019 - 2032 (USD Billion)
- 8.7.3. Latin America: Blood Transfusion Diagnostics Market, By End Use, 2019 - 2032 (USD Billion)
- 8.7.4. Blood Transfusion Diagnostics Market - Mexico
- 8.7.4.1. Mexico: Blood Transfusion Diagnostics Market, By Product, 2019 - 2032 (USD Billion)
- 8.7.4.2. Mexico.: Blood Transfusion Diagnostics Market, By Application, 2019 - 2032 (USD Billion)
- 8.7.4.3. Mexico: Blood Transfusion Diagnostics Market, By End Use, 2019 - 2032 (USD Billion)
- 8.7.5. Blood Transfusion Diagnostics Market - Brazil
- 8.7.5.1. Brazil: Blood Transfusion Diagnostics Market, By Product, 2019 - 2032 (USD Billion)
- 8.7.5.2. Brazil.: Blood Transfusion Diagnostics Market, By Application, 2019 - 2032 (USD Billion)
- 8.7.5.3. Brazil: Blood Transfusion Diagnostics Market, By End Use, 2019 - 2032 (USD Billion)
- 8.7.6. Blood Transfusion Diagnostics Market - Argentina
- 8.7.6.1. Argentina: Blood Transfusion Diagnostics Market, By Product, 2019 - 2032 (USD Billion)
- 8.7.6.2. Argentina.: Blood Transfusion Diagnostics Market, By Application, 2019 - 2032 (USD Billion)
- 8.7.6.3. Argentina: Blood Transfusion Diagnostics Market, By End Use, 2019 - 2032 (USD Billion)
9. Competitive Landscape
- 9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
- 9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
- 10.1. Abbott Laboratories
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
- 10.2. Bio-Rad Laboratories, Inc.
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
- 10.3. Diamond Diagnostics
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
- 10.4. Diagnostica Stago
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
- 10.5. Electro Medical Technologies
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
- 10.6. F. Hoffmann-La Roche Ltd
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
- 10.7. Grifols S.A.
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
- 10.8. Immucor Inc.
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
- 10.9. Ortho Clinical Diagnostics
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
- 10.10. Quotient Ltd
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development